Left ventricular dysfunction and outcome at two-year follow-up in patients with type 2 diabetes: The DYDA study

de Simone, 2010, Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study, J Hypertens, 28, 353, 10.1097/HJH.0b013e3283331169 Bobbio, 2003, Survival and hospitalization in heart failure patients with or without diabetes treated with beta-blockers, J Card Fail, 9, 192, 10.1054/jcaf.2003.31 Buyken, 2007, Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study, Eur J Cardiovasc Prev Rehabil, 14, 230, 10.1097/HJR.0b013e3280142037 Boonman-de Winter, 2012, High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes, Diabetologia, 55, 2154, 10.1007/s00125-012-2579-0 McMurray, 2012, Eur Heart J, 14, 803, 10.1093/eurjhf/hfs105 Fang, 2003, Echocardiographic detection of early diabetic myocardial disease, J Am Coll Cardiol, 41, 611, 10.1016/S0735-1097(02)02869-3 Chareonthaitawee, 2007, Prevalence and prognosis of left ventricular systolic dysfunction in asymptomatic diabetic patients without known coronary artery disease referred for stress single-photon emission computed tomography and assessment of left ventricular function, Am Heart J, 154, 567, 10.1016/j.ahj.2007.04.042 Galderisi, 2006, Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography, J Am Coll Cardiol, 48, 1548, 10.1016/j.jacc.2006.07.033 From, 2010, The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study, J Am Coll Cardiol, 55, 300, 10.1016/j.jacc.2009.12.003 Greenberg, 2010, Pre-clinical diastolic dysfunction in diabetic patients: where do we go from here?, J Am Coll Cardiol, 55, 306, 10.1016/j.jacc.2009.12.002 Cioffi, 2012, Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study, Eur J Prev Cardiol, 19, 935, 10.1177/1741826711417759 Giorda, 2011, Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study, Eur J Cardiovasc Prev Rehabil, 18, 415, 10.1177/1741826710389402 Casale, 1987, Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings, Circulation, 75, 565, 10.1161/01.CIR.75.3.565 Schiller, 1989, Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms, J Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8 Folland, 1979, Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques, Circulation, 60, 760, 10.1161/01.CIR.60.4.760 Quinones, 1981, A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography, Circulation, 64, 744, 10.1161/01.CIR.64.4.744 de Simone, 2002, Rationale of echocardiographic assessment of left ventricular wall stress and midwall mechanics in hypertensive heart disease, Eur J Echocardiogr, 3, 192, 10.1053/euje.3.3.192 Bella, 2006, Gender differences in left ventricular systolic function in American Indians (from the Strong Heart Study), Am J Cardiol, 98, 834, 10.1016/j.amjcard.2006.03.069 Redfield, 2003, Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic, JAMA, 289, 194, 10.1001/jama.289.2.194 de Simone, 2011, Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study, Nutr Metab Cardiovasc Dis Menzin, 2010, Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus, J Manag Care Pharm, 16, 264, 10.18553/jmcp.2010.16.4.264 Kilpatrick, 1996, The effects of ageing on glycation and the interpretation of glycaemic control in type 2 diabetes, QJM, 89, 307, 10.1093/qjmed/89.4.307 Ingelsson, 2005, Insulin resistance and risk of congestive heart failure, JAMA, 294, 334, 10.1001/jama.294.3.334 van Heerebeek, 2008, Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension, Circulation, 117, 43, 10.1161/CIRCULATIONAHA.107.728550 Cook, 2010, Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction, Eur Heart J, 31, 100, 10.1093/eurheartj/ehp396 Desrois, 2004, Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart, Cardiovasc Res, 61, 288, 10.1016/j.cardiores.2003.11.021 An, 2006, Role of changes in cardiac metabolism in development of diabetic cardiomyopathy, Am J Physiol Heart Circ Physiol, 291, 1489, 10.1152/ajpheart.00278.2006 Penjasković, 2012, Left ventricular diastolic dysfunction in patients with metabolic syndrome, Med Pregl, 65, 18, 10.2298/MPNS1202018P Boudina, 2007, Mitochondrial energetics in the heart in obesity related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins, Diabetes, 56, 2457, 10.2337/db07-0481 Vamos, 2012, Nationwide study on trends in hospital admissions for major cardiovascular events and procedures among people with and without diabetes in England, 2004–2009, Diabetes Care, 35, 265, 10.2337/dc11-1682 Adem, 2011, Trend of diabetic admissions in Tikur Anbessa and St. Paul's University Teaching Hospitals from January 2005–December 2009, Addis Ababa, Ethiopia, Ethiop Med J, 49, 231 Turner, 1998, Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23), BMJ, 316, 823, 10.1136/bmj.316.7134.823 Nichols, 2011, Change in high-density lipoprotein cholesterol and risk of subsequent hospitalization for coronary artery disease or stroke among patients with type 2 diabetes mellitus, Am J Cardiol, 108, 1124, 10.1016/j.amjcard.2011.05.047 Schramm, 2011, Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study, Eur Heart J, 32, 1900, 10.1093/eurheartj/ehr077 Marshall, 2006, Safety profile of repaglinide as used in general practice in England: results of a prescription-event monitoring study, Acta Diabetol, 43, 6, 10.1007/s00592-006-0203-9